Logo image of LH

LABCORP HOLDINGS INC (LH) Stock Fundamental Analysis

USA - NYSE:LH - US5049221055 - Common Stock

252.33 USD
+4.19 (+1.69%)
Last: 10/30/2025, 4:24:01 PM
252.33 USD
0 (0%)
After Hours: 10/30/2025, 4:24:01 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to LH. LH was compared to 101 industry peers in the Health Care Providers & Services industry. Both the profitability and the financial health of LH get a neutral evaluation. Nothing too spectacular is happening here. LH is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

LH had positive earnings in the past year.
In the past year LH had a positive cash flow from operations.
LH had positive earnings in each of the past 5 years.
In the past 5 years LH always reported a positive cash flow from operatings.
LH Yearly Net Income VS EBIT VS OCF VS FCFLH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

1.2 Ratios

The Return On Assets of LH (4.23%) is better than 72.28% of its industry peers.
LH has a Return On Equity of 9.01%. This is in the better half of the industry: LH outperforms 70.30% of its industry peers.
The Return On Invested Capital of LH (5.82%) is better than 61.39% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LH is below the industry average of 9.34%.
Industry RankSector Rank
ROA 4.23%
ROE 9.01%
ROIC 5.82%
ROA(3y)4.3%
ROA(5y)6.46%
ROE(3y)9.08%
ROE(5y)13.4%
ROIC(3y)6.31%
ROIC(5y)8.87%
LH Yearly ROA, ROE, ROICLH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

LH has a better Profit Margin (5.66%) than 79.21% of its industry peers.
LH's Profit Margin has declined in the last couple of years.
LH has a Operating Margin of 9.15%. This is in the better half of the industry: LH outperforms 77.23% of its industry peers.
LH's Operating Margin has declined in the last couple of years.
LH's Gross Margin of 28.14% is in line compared to the rest of the industry. LH outperforms 55.45% of its industry peers.
In the last couple of years the Gross Margin of LH has remained more or less at the same level.
Industry RankSector Rank
OM 9.15%
PM (TTM) 5.66%
GM 28.14%
OM growth 3Y-27.95%
OM growth 5Y-7.41%
PM growth 3Y-31.82%
PM growth 5Y-4.26%
GM growth 3Y-9.83%
GM growth 5Y-0.21%
LH Yearly Profit, Operating, Gross MarginsLH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

5

2. Health

2.1 Basic Checks

LH has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, LH has less shares outstanding
The number of shares outstanding for LH has been reduced compared to 5 years ago.
Compared to 1 year ago, LH has a worse debt to assets ratio.
LH Yearly Shares OutstandingLH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
LH Yearly Total Debt VS Total AssetsLH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

2.2 Solvency

An Altman-Z score of 3.01 indicates that LH is not in any danger for bankruptcy at the moment.
The Altman-Z score of LH (3.01) is better than 60.40% of its industry peers.
The Debt to FCF ratio of LH is 4.48, which is a neutral value as it means it would take LH, 4.48 years of fcf income to pay off all of its debts.
LH's Debt to FCF ratio of 4.48 is fine compared to the rest of the industry. LH outperforms 72.28% of its industry peers.
LH has a Debt/Equity ratio of 0.61. This is a neutral value indicating LH is somewhat dependend on debt financing.
The Debt to Equity ratio of LH (0.61) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.48
Altman-Z 3.01
ROIC/WACC0.68
WACC8.54%
LH Yearly LT Debt VS Equity VS FCFLH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

2.3 Liquidity

LH has a Current Ratio of 1.50. This is a normal value and indicates that LH is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of LH (1.50) is comparable to the rest of the industry.
A Quick Ratio of 1.32 indicates that LH should not have too much problems paying its short term obligations.
LH's Quick ratio of 1.32 is in line compared to the rest of the industry. LH outperforms 47.52% of its industry peers.
Industry RankSector Rank
Current Ratio 1.5
Quick Ratio 1.32
LH Yearly Current Assets VS Current LiabilitesLH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B 5B

5

3. Growth

3.1 Past

LH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.71%, which is quite good.
LH shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 5.20% yearly.
LH shows a small growth in Revenue. In the last year, the Revenue has grown by 6.97%.
The Revenue has been growing slightly by 2.40% on average over the past years.
EPS 1Y (TTM)9.71%
EPS 3Y-20.05%
EPS 5Y5.2%
EPS Q2Q%19.43%
Revenue 1Y (TTM)6.97%
Revenue growth 3Y-0.32%
Revenue growth 5Y2.4%
Sales Q2Q%8.58%

3.2 Future

LH is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.10% yearly.
The Revenue is expected to grow by 4.12% on average over the next years.
EPS Next Y15.34%
EPS Next 2Y11.5%
EPS Next 3Y10.73%
EPS Next 5Y9.1%
Revenue Next Year7.85%
Revenue Next 2Y6.31%
Revenue Next 3Y5.84%
Revenue Next 5Y4.12%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
LH Yearly Revenue VS EstimatesLH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B
LH Yearly EPS VS EstimatesLH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20 25

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 15.95, the valuation of LH can be described as correct.
LH's Price/Earnings ratio is a bit cheaper when compared to the industry. LH is cheaper than 79.21% of the companies in the same industry.
When comparing the Price/Earnings ratio of LH to the average of the S&P500 Index (26.76), we can say LH is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 13.93, the valuation of LH can be described as correct.
Compared to the rest of the industry, the Price/Forward Earnings ratio of LH indicates a somewhat cheap valuation: LH is cheaper than 79.21% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.63. LH is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 15.95
Fwd PE 13.93
LH Price Earnings VS Forward Price EarningsLH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LH is valued a bit cheaper than the industry average as 60.40% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of LH indicates a somewhat cheap valuation: LH is cheaper than 75.25% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 16.62
EV/EBITDA 13.46
LH Per share dataLH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

LH's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.04
PEG (5Y)3.07
EPS Next 2Y11.5%
EPS Next 3Y10.73%

5

5. Dividend

5.1 Amount

LH has a Yearly Dividend Yield of 1.11%. Purely for dividend investing, there may be better candidates out there.
LH's Dividend Yield is rather good when compared to the industry average which is at 2.42. LH pays more dividend than 84.16% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.31, LH's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.11%

5.2 History

The dividend of LH is nicely growing with an annual growth rate of 96.38%!
LH has been paying a dividend for over 5 years, so it has already some track record.
LH has decreased its dividend in the last 3 years.
Dividend Growth(5Y)96.38%
Div Incr Years2
Div Non Decr Years2
LH Yearly Dividends per shareLH Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 1 2 3

5.3 Sustainability

31.71% of the earnings are spent on dividend by LH. This is a low number and sustainable payout ratio.
LH's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP31.71%
EPS Next 2Y11.5%
EPS Next 3Y10.73%
LH Yearly Income VS Free CF VS DividendLH Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B
LH Dividend Payout.LH Dividend Payout, showing the Payout Ratio.LH Dividend Payout.PayoutRetained Earnings

LABCORP HOLDINGS INC

NYSE:LH (10/30/2025, 4:24:01 PM)

After market: 252.33 0 (0%)

252.33

+4.19 (+1.69%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)10-28 2025-10-28/bmo
Earnings (Next)02-04 2026-02-04
Inst Owners100.29%
Inst Owner Change0.25%
Ins Owners0.33%
Ins Owner Change-3.21%
Market Cap20.97B
Revenue(TTM)13.01B
Net Income(TTM)763.40M
Analysts83.45
Price Target307.03 (21.68%)
Short Float %2.95%
Short Ratio4.88
Dividend
Industry RankSector Rank
Dividend Yield 1.11%
Yearly Dividend2.91
Dividend Growth(5Y)96.38%
DP31.71%
Div Incr Years2
Div Non Decr Years2
Ex-Date11-26 2025-11-26 (0.72)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)0.49%
Min EPS beat(2)-0.37%
Max EPS beat(2)1.34%
EPS beat(4)1
Avg EPS beat(4)-0.64%
Min EPS beat(4)-2.46%
Max EPS beat(4)1.34%
EPS beat(8)3
Avg EPS beat(8)-0.23%
EPS beat(12)4
Avg EPS beat(12)-0.7%
EPS beat(16)7
Avg EPS beat(16)2.58%
Revenue beat(2)0
Avg Revenue beat(2)-3.07%
Min Revenue beat(2)-4.4%
Max Revenue beat(2)-1.75%
Revenue beat(4)0
Avg Revenue beat(4)-2.68%
Min Revenue beat(4)-4.4%
Max Revenue beat(4)-1.75%
Revenue beat(8)0
Avg Revenue beat(8)-2.1%
Revenue beat(12)0
Avg Revenue beat(12)-7.84%
Revenue beat(16)1
Avg Revenue beat(16)-12.95%
PT rev (1m)0%
PT rev (3m)5.45%
EPS NQ rev (1m)0.41%
EPS NQ rev (3m)1.69%
EPS NY rev (1m)0%
EPS NY rev (3m)1.37%
Revenue NQ rev (1m)0.16%
Revenue NQ rev (3m)1.02%
Revenue NY rev (1m)0.02%
Revenue NY rev (3m)0.8%
Valuation
Industry RankSector Rank
PE 15.95
Fwd PE 13.93
P/S 1.56
P/FCF 16.62
P/OCF 12.38
P/B 2.47
P/tB N/A
EV/EBITDA 13.46
EPS(TTM)15.82
EY6.27%
EPS(NY)18.11
Fwd EY7.18%
FCF(TTM)15.18
FCFY6.02%
OCF(TTM)20.38
OCFY8.08%
SpS162.26
BVpS101.96
TBVpS-18.93
PEG (NY)1.04
PEG (5Y)3.07
Graham Number190.5
Profitability
Industry RankSector Rank
ROA 4.23%
ROE 9.01%
ROCE 8.04%
ROIC 5.82%
ROICexc 6.08%
ROICexgc 19.2%
OM 9.15%
PM (TTM) 5.66%
GM 28.14%
FCFM 9.36%
ROA(3y)4.3%
ROA(5y)6.46%
ROE(3y)9.08%
ROE(5y)13.4%
ROIC(3y)6.31%
ROIC(5y)8.87%
ROICexc(3y)6.66%
ROICexc(5y)9.53%
ROICexgc(3y)24.5%
ROICexgc(5y)35.7%
ROCE(3y)8.72%
ROCE(5y)12.25%
ROICexgc growth 3Y-23.52%
ROICexgc growth 5Y-8.03%
ROICexc growth 3Y-23.85%
ROICexc growth 5Y-3.15%
OM growth 3Y-27.95%
OM growth 5Y-7.41%
PM growth 3Y-31.82%
PM growth 5Y-4.26%
GM growth 3Y-9.83%
GM growth 5Y-0.21%
F-Score7
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.48
Debt/EBITDA 2.7
Cap/Depr 64.52%
Cap/Sales 3.2%
Interest Coverage 4.52
Cash Conversion 89%
Profit Quality 165.29%
Current Ratio 1.5
Quick Ratio 1.32
Altman-Z 3.01
F-Score7
WACC8.54%
ROIC/WACC0.68
Cap/Depr(3y)76.91%
Cap/Depr(5y)70.72%
Cap/Sales(3y)3.85%
Cap/Sales(5y)3.56%
Profit Quality(3y)157.09%
Profit Quality(5y)139.08%
High Growth Momentum
Growth
EPS 1Y (TTM)9.71%
EPS 3Y-20.05%
EPS 5Y5.2%
EPS Q2Q%19.43%
EPS Next Y15.34%
EPS Next 2Y11.5%
EPS Next 3Y10.73%
EPS Next 5Y9.1%
Revenue 1Y (TTM)6.97%
Revenue growth 3Y-0.32%
Revenue growth 5Y2.4%
Sales Q2Q%8.58%
Revenue Next Year7.85%
Revenue Next 2Y6.31%
Revenue Next 3Y5.84%
Revenue Next 5Y4.12%
EBIT growth 1Y8.75%
EBIT growth 3Y-28.19%
EBIT growth 5Y-5.19%
EBIT Next Year33.62%
EBIT Next 3Y14.33%
EBIT Next 5Y11.34%
FCF growth 1Y15.01%
FCF growth 3Y-25.49%
FCF growth 5Y0.97%
OCF growth 1Y12.91%
OCF growth 3Y-20.11%
OCF growth 5Y1.88%

LABCORP HOLDINGS INC / LH FAQ

Can you provide the ChartMill fundamental rating for LABCORP HOLDINGS INC?

ChartMill assigns a fundamental rating of 5 / 10 to LH.


What is the valuation status of LABCORP HOLDINGS INC (LH) stock?

ChartMill assigns a valuation rating of 5 / 10 to LABCORP HOLDINGS INC (LH). This can be considered as Fairly Valued.


What is the profitability of LH stock?

LABCORP HOLDINGS INC (LH) has a profitability rating of 5 / 10.


Can you provide the PE and PB ratios for LH stock?

The Price/Earnings (PE) ratio for LABCORP HOLDINGS INC (LH) is 15.95 and the Price/Book (PB) ratio is 2.47.


What is the financial health of LABCORP HOLDINGS INC (LH) stock?

The financial health rating of LABCORP HOLDINGS INC (LH) is 5 / 10.